Bank of Montreal
RCKT icon

Bank of Montreal’s Rocket Pharmaceuticals RCKT Stock Holding History

Bank of Montreal’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30,500
Closed -$942K – 4244
2023
Q4 		$942K Sell
30,500
-4,500
-13% -$99.3K ﹤0.01% 2080
2023
Q3 		$825K Buy
+35,000
New +$636K ﹤0.01% 2160

Other funds holding RCKT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Bank of Montreal's RCKT Position: Q2 2026 in Review

Bank of Montreal reduced its Rocket Pharmaceuticals (RCKT) stake by 10% in Q2 2026, selling an estimated $27.1K and leaving 70,399 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #2894.

Bank of Montreal first reported a position in RCKT in Q3 2015 and has held it in 25 quarters since. The position peaked at $365K in Q4 2020. 93 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Bank of Montreal held 70,399 shares of Rocket Pharmaceuticals worth $241K as of Q2 2026.
  • Bank of Montreal sold 8,159 Rocket Pharmaceuticals shares in Q2 2026, an estimated $27.1K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2894 holding.
  • Bank of Montreal first reported a position in Rocket Pharmaceuticals in Q3 2015 and has held it in 25 quarters since.
  • Bank of Montreal's Rocket Pharmaceuticals position peaked at $365K in Q4 2020.
  • 93 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.